Skip to content
Sharism- Lifestyle
Author:
Rise Therapeutics
Rise Therapeutics Completes Dose Escalation in R-5780 Phase 1 Cancer Trial, Advances to Dose Expansion
September 22, 2026
Rise Therapeutics Completes Enrollment in Four-Week Dose Expansion Cohort for the R-2487 Rheumatoid Arthritis Clinical Trial
June 2, 2026